← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 13, 2018Last known activity
Mar 10, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 7 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT07008365Lead sponsorPhase 3Mar 10, 2025
- NCT06296082CollaboratorPhase 2/Phase 3Jul 1, 2024
- NCT04959331CollaboratorPhase 4Nov 2, 2021
- NCT04824053Reponsible party - principal investigatorN/ANov 1, 2021
- NCT04824053Lead sponsorN/ANov 1, 2021
- NCT04385966Lead sponsorPhase 3Feb 11, 2020
- NCT03957902Lead sponsorPhase 2May 6, 2019
- NCT03957902Overall official - principal investigatorPhase 2May 6, 2019
- NCT03957902Reponsible party - principal investigatorPhase 2May 6, 2019
- NCT04028258Overall official - principal investigatorN/AFeb 13, 2018
Details
- Last known activity
- Mar 10, 2025